Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Margherita Strolin Benedetti, Rhys Whomsley & Eugène Baltes. (2006) Involvement of enzymes other than CYPs in the oxidative metabolism of xenobiotics. Expert Opinion on Drug Metabolism & Toxicology 2:6, pages 895-921.
Read now
Read now
Bin Gong & Paul J Boor. (2006) The role of amine oxidases in xenobiotic metabolism. Expert Opinion on Drug Metabolism & Toxicology 2:4, pages 559-571.
Read now
Read now
M. STROLIN BENEDETTI & M. BANI. (1999) METABOLISM-BASED DRUG INTERACTIONS INVOLVING ORAL AZOLE ANTIFUNGALS IN HUMANS*. Drug Metabolism Reviews 31:3, pages 665-717.
Read now
Read now
Articles from other publishers (22)
JOE R. CANNON, PRAKASH VACHASPATI & YANG YUAN. 2022. Drug Metabolism Handbook. Drug Metabolism Handbook
41
101
.
Donald J. AbrahamDeepak K. Dalvie & Bernard Testa. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
139
.
Chang-Hwei ChenChang-Hwei Chen. 2020. Xenobiotic Metabolic Enzymes: Bioactivation and Antioxidant Defense. Xenobiotic Metabolic Enzymes: Bioactivation and Antioxidant Defense
59
70
.
Chun Li & Nataraj Kalyanaraman. 2012. ADME‐Enabling Technologies in Drug Design and Development. ADME‐Enabling Technologies in Drug Design and Development
189
212
.
Pavel Anzenbacher & Eva Anzenbacherová. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics
1
25
.
Chang-Hwei ChenChang-Hwei Chen. 2012. Activation and Detoxification Enzymes. Activation and Detoxification Enzymes
137
144
.
Marc Lübberstedt, Ursula Müller-Vieira, Manuela Mayer, Klaus M. Biemel, Fanny Knöspel, Daniel Knobeloch, Andreas K. Nüssler, Jörg C. Gerlach & Katrin Zeilinger. (2011) HepaRG human hepatic cell line utility as a surrogate for primary human hepatocytes in drug metabolism assessment in vitro. Journal of Pharmacological and Toxicological Methods 63:1, pages 59-68.
Crossref
Crossref
John A. Timbrell & Timothy C. Marrs. 2009. General, Applied and Systems Toxicology. General, Applied and Systems Toxicology.
John Timbrell. 2008. Principles of Biochemical Toxicology, Fourth Edition. Principles of Biochemical Toxicology, Fourth Edition
75
127
.
Margherita Strolin Benedetti, Keith F. Tipton & Rhys Whomsley. (2007) Amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans: has the involvement of amine oxidases been neglected?. Fundamental & Clinical Pharmacology 21:5, pages 467-480.
Crossref
Crossref
Bernard Testa & Stefanie D. Krämer. (2007) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 4:3, pages 257-405.
Crossref
Crossref
Michael P. Valley, Wenhui Zhou, Erika M. Hawkins, John Shultz, James J. Cali, Tracy Worzella, Laurent Bernad, Troy Good, Dave Good, Terry L. Riss, Dieter H. Klaubert & Keith V. Wood. (2006) A bioluminescent assay for monoamine oxidase activity. Analytical Biochemistry 359:2, pages 238-246.
Crossref
Crossref
Jesse A. May, Hwang-Hsing Chen, Andrew Rusinko, Vincent M. Lynch, Najam A. Sharif & Marsha A. McLaughlin. (2003)
A Novel and Selective 5-HT
2
Receptor Agonist with Ocular Hypotensive Activity: (
S
)-(+)-1-(2-Aminopropyl)-8,9-dihydropyrano[3,2-
e
]indole
. Journal of Medicinal Chemistry 46:19, pages 4188-4195.
Crossref
Crossref
Miquel Salva, Josep M. Jansat, Antonio Martinez-Tobed & Jose M. Palacios. (2003) Identification of the Human Liver Enzymes Involved in the Metabolism of the Antimigraine Agent Almotriptan. Drug Metabolism and Disposition 31:4, pages 404-411.
Crossref
Crossref
Michael R. Goldberg, David Sciberras, Marina De Smet, Richard Lowry, Lisa Tomasko, Yih Lee, Timothy V. Olah, Jamie Zhao, Kamlesh P. Vyas, Rita Halpin, Prasad H. Kari & Ian James. (2001)
Influence of β‐adrenoceptor antagonists on the pharmacokinetics of rizatriptan, a 5‐HT
1B/1D
agonist: differential effects of propranolol, nadolol and metoprolol
. British Journal of Clinical Pharmacology 52:1, pages 69-76.
Crossref
Crossref
Margherita Strolin Benedetti. (2001) Biotransformation of xenobiotics by amine oxidases. Fundamental & Clinical Pharmacology 15:2, pages 75-84.
Crossref
Crossref
Ramon El-Bacha, Philippe Lagrange, Daniela Gradinaru, Funmilayo Suleman, Alain Minn & Claire Bayol-Denizot. 2000. The Blood-Brain Barrier and Drug Delivery to the CNS. The Blood-Brain Barrier and Drug Delivery to the CNS.
Carl G.H. Dahlof, Alan M. Rapoport, Fred D. Sheftell & Christopher R. Lines. (1999) Rizatriptan in the treatment of migraine. Clinical Therapeutics 21:11, pages 1823-1836.
Crossref
Crossref
Nonggao He, Sharad S Singhal, Sanjay Awasthi, Tiejun Zhao & Paul J Boor. (1999) Role of Glutathione S-transferase 8-8 in Allylamine Resistance of Vascular Smooth Muscle Cells in Vitro. Toxicology and Applied Pharmacology 158:2, pages 177-185.
Crossref
Crossref
Gordon W. Glazner. 1999. Genetic Aberrancies and Neurodegenerative Disorders. Genetic Aberrancies and Neurodegenerative Disorders
313
354
.
M. Strolin Benedetti & K. F. Tipton. 1998. MAO — The Mother of all Amine Oxidases. MAO — The Mother of all Amine Oxidases
149
171
.
Makoto Naoi, Wakako Maruyama, Jian Hua Zhang, Tsutomu Takahashi, Yulin Deng & Philippe Dostert. (1995) Enzymatic oxidation of the dopaminergic neurotoxin, 1 (R), 2(N)-Dimethyl-6,7-Dihydroxy-l,2,3,4-Tetrahydroisoquinoline, into 1,2(N)-Dimethyl-6,7-Dihydroxyisoquinolinium ion. Life Sciences 57:11, pages 1061-1066.
Crossref
Crossref